Patrick F. Williams - 03 Nov 2022 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role
Director
Signature
/s/ Patrick F. Williams
Issuer symbol
BRTX
Transactions as of
03 Nov 2022
Net transactions value
$0
Form type
4
Filing time
04 Nov 2022, 16:19:48 UTC
Previous filing
08 Jun 2022
Next filing
17 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BRTX Stock Option Disposed to Issuer $0 -10,490 -100% $0.000000* 0 03 Nov 2022 Common Stock 10,490 $13.50 Direct F1, F2
transaction BRTX Stock Option Award $0 +10,490 $0.000000 10,490 03 Nov 2022 Common Stock 10,490 $5.08 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in eight nearly-equal quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested.
F2 The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option with a reduced exercise price.